Cladribine (Mavenclad) can cost up to $99,500 per year. Learn how to save with copay programs, generic options, patient assistance, and other discount strategies in 2026.
Let's start with the number that probably brought you here: Mavenclad (brand-name Cladribine) costs approximately $99,500 per annual treatment course at list price. For the full 2-year treatment, that's nearly $200,000 before insurance.
If that number made your stomach drop, you're not alone. Cladribine is one of the most effective oral treatments for relapsing multiple sclerosis, but it's also one of the most expensive. The good news? Very few patients actually pay the list price. Between manufacturer programs, generic options, patient assistance, and discount strategies, most people can bring their costs down dramatically.
Here's everything you need to know about saving money on Cladribine in 2026.
If you're paying entirely out of pocket with no insurance and no assistance programs, here's what you're looking at:
These are sticker prices. Keep reading — the actual amount you pay can be far less.
If you have commercial health insurance (employer-provided, marketplace plan, or private insurance), EMD Serono offers the Mavenclad Co-pay Program. This can reduce your out-of-pocket cost to as low as $0-$25 per treatment course.
Key details:
This program is by far the most impactful savings opportunity for commercially insured patients. If you have commercial insurance and are prescribed Mavenclad, enroll in this program immediately.
In November 2025, the FDA approved generic Cladribine tablets (10 mg) manufactured by Apotex Inc. This is the first generic alternative to brand-name Mavenclad.
What this means for savings:
Ask your prescriber and specialty pharmacy whether the generic is available and which option makes more financial sense for your situation.
If you have no insurance, or if your insurance doesn't cover Cladribine, these programs can help:
EMD Serono's MS LifeLines provides free Mavenclad to qualifying patients who are uninsured or underinsured. This is a needs-based program — eligibility depends on income and insurance status.
The PAN Foundation offers copay assistance grants for patients with MS. When funds are available, they can cover a significant portion of your out-of-pocket costs for Cladribine.
HealthWell Foundation offers grants for MS patients to help cover prescription costs, including specialty medications like Cladribine.
NeedyMeds maintains a comprehensive database of patient assistance programs, discount cards, and copay programs. Search for Cladribine or Mavenclad to find all available options.
The National MS Society (1-800-344-4867) provides financial assistance and can connect you with MS Navigators who help troubleshoot insurance and cost issues.
If your insurance denies coverage for Cladribine, don't give up. You have the right to appeal. Many denials are reversed on appeal, especially when your doctor provides detailed documentation of medical necessity. Ask your doctor's office to file the appeal, and contact MS LifeLines for assistance with the process.
Some insurance plans allow tier exceptions — if you can demonstrate that Cladribine is medically necessary and other options have failed, the plan may move it to a lower cost-sharing tier. Your doctor can request this through the insurance company.
Some states offer their own prescription assistance programs for residents with high medication costs. Check with your state's department of health or insurance commissioner to see if you qualify.
If your total medical expenses — including medication costs — exceed 7.5% of your adjusted gross income, you may be able to deduct them on your federal tax return. Keep records of all Cladribine-related expenses.
You may find Cladribine listed on discount card sites like GoodRx, SingleCare, or RxSaver. While these can sometimes help with generic medications, they have limited utility for specialty medications like Mavenclad:
GoodRx lists prices starting at approximately $22,115 for Mavenclad with a coupon — which is meaningful for uninsured patients but still higher than what the copay program or patient assistance can provide.
Cladribine's list price is eye-watering, but the reality for most patients is much better. Between the Mavenclad Co-pay Program ($0-$25 for commercially insured), the new generic option, patient assistance programs for the uninsured, and foundation grants, the majority of patients can access Cladribine at a fraction of the sticker price.
The key is to start exploring savings options at the same time as your prescription — not after you get the first bill. Ask your doctor's office to enroll you in MS LifeLines, check your insurance benefits, and apply for foundation grants early.
For more on accessing Cladribine, visit our guides on finding Cladribine in stock and why Cladribine is hard to find. You can also use Medfinder to locate pharmacies with availability near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
